ArticleInternational journal of clinical and experimental pathology2018

Targeting STAT3 restores BRAF inhibitor sensitivity through miR-759-3p in human cutaneous melanoma cells.

Yipeng Su et al.PubMed ↗Full text ↗

No numbers read from the abstract.